| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COAGULATION FACTOR IX RECOMBINANT HUMAN | 2 | 0.0018 |
| 1 | ANTIHEMOPHILIC FACTOR HUMAN | 2 | 0.0015 |
| 2 | ANTI-INHIBITOR COAGULANT COMPLEX | 1 | 0.0009 |
| 3 | COAGULATION FACTOR IX (RECOMBINANT), FC FUSION PROTEIN | 2 | 0.0008 |
| 4 | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 6 | 0.0007 |
| 5 | EMICIZUMAB | 8 | 0.0006 |
| 6 | RALTEGRAVIR | 2 | 0.0004 |
| 7 | COAGULATION FACTOR VIIA (RECOMBINANT) | 1 | 0.0004 |
| 8 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 2 | 0.0003 |
| 9 | DOLUTEGRAVIR SODIUM | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 3 | 0.0001 |
| 1 | Hepatitis C Virus NS5A Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Methylxanthine [EPC] | 1 | 0.0000 |
| 7 | Histamine-2 Receptor Antagonist [EPC] | 2 | 0.0000 |
| 8 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |
| 9 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 1 | 0.0000 |